Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares. AI is about to change ...

Meeting to be held in Boston on April 9 and in New York on April 10 hosted by Piper Sandler.Stay Ahead of the Market: Discover outperforming ...

Schroder Investment Management Group lessened its position in Altimmune, Inc. (NASDAQ:ALT – Free Report) by 9.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm ...

HC Wainwright reaffirmed their buy rating on shares of Altimmune (NASDAQ:ALT – Free Report) in a research report sent to ...

Altimmune has a huge opportunity with its promising GLP-1 drug. Moderna isn't just a pandemic stock. Pfizer is trading at a ridiculously cheap valuation and pays a juicy dividend. David Jagielski ...

In this article, we will see how Altimmune, Inc. (NASDAQ:ALT) compares to the other top short squeeze stocks that have received a Buy rating from analysts. Stock market trading has an ever ...